VectorY Therapeutics
PrivateLast Round
Series A
Nov 13, 2023
Total Funding Raised
$176M
Company Overview
VectorY Therapeutics is a biotechnology company that develops vectorized antibody therapies for neurodegenerative diseases including ALS, Huntington's, and Parkinson's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VectorY Therapeutics Comparables
Compare VectorY Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Capsida Biotherapeutics | 81% | |
| Coave Therapeutics | 77% | |
| Voyager Therapeutics | 76% | |
VectorY Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 13, 2023 | ||||
| Seed | Jun 15, 2021 |
Key People
Founding team and executive leadership
VectorY Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EQT Life Sciences | Series A |
| Forbion | Series A, Seed |
| ALS Investment Fund | Series A |
| BioGeneration Ventures | Series A, Seed |
| Insight Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 16, 2025
Developing vectorized antibody therapies with Shape Therapeutics.
- Dec 16, 2025
Collaborating with Shape Therapeutics on vectorized antibody therapies for neurodegenerative diseases.
VectorY Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about VectorY Therapeutics's valuation, stock price, and market status.